The National Treatment Purchase Fund looks to source treatment or an appointment for all patients waiting more than 3 months subject to available public and private capacity.
As part of the 2023 Waiting List Action Plan (WLAP) 20 specific high volume procedures were identified, that at the end of 2022 accounted for more than 40% of the IPDC waiting list, with a commitment that anyone waiting 3 months or over who is clinically suitable will receive an offer of care from the NTPF. As at the end of August, 80% of patients waiting more than 3 months have either been removed from the waiting list or have received an authorisation for an offer of NTPF funded treatment.
The Waiting List Task Force continues to meet monthly and oversee progress of the delivery of the 2023 Plan, including updates from the NTPF in relation to the 20 high volume procedures identified in the Plan. The Task Force then provides regular updates to me and the Sláintecare Programme Board.